Deniz Kirik

19.6k total citations · 6 hit papers
170 papers, 15.6k citations indexed

About

Deniz Kirik is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Deniz Kirik has authored 170 papers receiving a total of 15.6k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Cellular and Molecular Neuroscience, 85 papers in Neurology and 62 papers in Molecular Biology. Recurrent topics in Deniz Kirik's work include Nerve injury and regeneration (81 papers), Parkinson's Disease Mechanisms and Treatments (76 papers) and Neurological disorders and treatments (45 papers). Deniz Kirik is often cited by papers focused on Nerve injury and regeneration (81 papers), Parkinson's Disease Mechanisms and Treatments (76 papers) and Neurological disorders and treatments (45 papers). Deniz Kirik collaborates with scholars based in Sweden, United States and Australia. Deniz Kirik's co-authors include Anders Björklund, Carl Rosenblad, Olle Lindvall, Zaal Kokaia, Andreas Arvidsson, Christian Winkler, Ronald J. Mandel, Biljana Georgievska, Thomas Carlsson and Cecilia Lundberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Medicine.

In The Last Decade

Deniz Kirik

167 papers receiving 15.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuronal replacement from endogenous precursors in the adult brain after stroke

2002 2.3k citations Deniz Kirik et al. profile →
Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the Rat

1998 556 citations Deniz Kirik, Carl Rosenblad et al. profile →
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease

2002 552 citations Deniz Kirik et al. profile →
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

2002 550 citations Deniz Kirik, Carl Rosenblad et al. profile →
Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System

2002 519 citations Deniz Kirik, Carl Rosenblad et al. Journal of Neuroscience profile →
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

2007 511 citations Deniz Kirik, Anders Björklund et al. profile →

Peers

Countries citing papers authored by Deniz Kirik

Since Specialization

Citations

This map shows the geographic impact of Deniz Kirik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deniz Kirik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deniz Kirik more than expected).

Fields of papers citing papers by Deniz Kirik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deniz Kirik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deniz Kirik. The network helps show where Deniz Kirik may publish in the future.

Co-authorship network of co-authors of Deniz Kirik

This figure shows the co-authorship network connecting the top 25 collaborators of Deniz Kirik. A scholar is included among the top collaborators of Deniz Kirik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deniz Kirik. Deniz Kirik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons 2024 ·Biology ·(unknown), Máté D. Döbrössy, Lachlan H. Thompson, Deniz Kirik, Heidi R. Fuller, Monte Gates	3
2	Image post-processing for SILMAS: structured illumination light sheet microscopy with axial sweeping 2024 ·Biomedical Optics Express ·(unknown), (unknown), Allison J. Schaser, Deniz Kirik, Elias Kristensson, Edouard Berrocal	0
3	Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain 2024 ·npj Parkinson s Disease ·Benjamin G. Trist, (unknown), Alejandra Rangel, Louise Cottle, (unknown), Nanna Møller Jensen, Hjalte Gram, Nicolas Dzamko, Poul Henning Jensen, Deniz Kirik	0
4	Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Deniz Kirik, Laurie H. Sanders, Lei S. Qi, Birgitt Schüle	8
5	Effects of mutant huntingtin in oxytocin neurons on non‐motor features of Huntington's disease 2023 ·Neuropathology and Applied Neurobiology ·(unknown), Sanaz Gabery, (unknown), Deniz Kirik, Åsa Petersén, Rachel Y. Cheong	2
6	High contrast, isotropic, and uniform 3D-imaging of centimeter-scale scattering samples using structured illumination light-sheet microscopy with axial sweeping 2022 ·Biomedical Optics Express ·(unknown), (unknown), Allison J. Schaser, Deniz Kirik, Edouard Berrocal	4
7	A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells 2022 ·Cell stem cell ·Niamh Moriarty, Carlos W. Gantner, Cameron J. Hunt, Charlotte M. Ermine, (unknown), (unknown), Dmitry A. Ovchinnikov, Deniz Kirik, Clare L. Parish, Lachlan H. Thompson	46
8	Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease 2021 ·Movement Disorders ·(unknown), YuHong Fu, Deniz Kirik, James M. Shine, Glenda M. Halliday	29
9	DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease 2021 ·Neurobiology of Disease ·(unknown), (unknown), Deniz Kirik, Christian Hansen	23
10	How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease? 2016 ·Journal of Neurochemistry ·Laura A. Volpicelli‐Daley, Deniz Kirik, Lindsay E. Stoyka, David G. Standaert, Ashley S. Harms	87
11	Optogenetic inhibition of chemically induced hypersynchronized bursting in mice 2014 ·Neurobiology of Disease ·(unknown), Marco Ledri, Andreas T. Sørensen, Litsa Nikitidou, Miriam Melis, Pascal Bielefeld, Deniz Kirik, Karl Deisseroth, My Andersson, Mérab Kokaia	42
12	Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra 2013 ·Movement Disorders ·Stefanie Reyes, Veronica Cottam, Deniz Kirik, Kay L. Double, Glenda M. Halliday	23
13	Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease 2012 ·Neurobiology of Aging ·Stefanie Reyes, YuHong Fu, Kay L. Double, Veronica Cottam, Lachlan H. Thompson, Deniz Kirik, George Paxinos, Charles Watson, Helen Cooper, Glenda M. Halliday	45
14	Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates 2012 ·Neuroscience ·Pernille Barkholt, Vanesa Sánchez-Guajardo, Deniz Kirik, Marina Romero‐Ramos	63
15	Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses 2010 ·Acta Neuropathologica ·Sanaz Gabery, Karen E. Murphy, (unknown), Clement T. Loy, Elizabeth McCusker, Deniz Kirik, Glenda M. Halliday, Åsa Petersén	91
16	Scientific rationale for the development of gene therapy strategies for Parkinson's disease 2009 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Tomas Björklund, Deniz Kirik	32
17	Dose Optimization for Long-term rAAV-mediated RNA Interference in the Nigrostriatal Projection Neurons 2009 ·Molecular Therapy ·Ayşe Ulusoy, Gürdal Şahin, Tomas Björklund, Patrick Aebischer, Deniz Kirik	56
18	Overexpression of Glial Cell Line-Derived Neurotrophic Factor Using a Lentiviral Vector Induces Time- and Dose-Dependent Downregulation of Tyrosine Hydroxylase in the Intact Nigrostriatal Dopamine System 2004 ·Journal of Neuroscience ·Biljana Georgievska, Deniz Kirik, Anders Björklund	127
19	Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model11Published on the World Wide Web on 10 October 2000. 2000 ·Brain Research ·Anders Björklund, Deniz Kirik, Carl Rosenblad, Biljana Georgievska, Cecilia Lundberg, Ronald J. Mandel	274
20	Long-Term rAAV-Mediated Gene Transfer of GDNF in the Rat Parkinson's Model: Intrastriatal But Not Intranigral Transduction Promotes Functional Regeneration in the Lesioned Nigrostriatal System 2000 ·Journal of Neuroscience ·Deniz Kirik, Carl Rosenblad, Anders Björklund, Ronald J. Mandel	342

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact